Bruce C. Cozadd, Director at Jazz Pharmaceuticals plc (JAZZ), sold 36,000 shares at $180.09 ($6.5M) on 2025-11-18, disclosed to the SEC on 2025-11-20.
Seasonal sale ($6.5M) by Director — this insider has traded JAZZ in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $180.09 | 3,384 | $609K | 9.3% |
| 2 | $180.09 | 3,384 | $609K | 9.3% |
| 3 | $180.88 | 8,382 | $1.5M | 23.3% |
| 4 | $180.88 | 8,382 | $1.5M | 23.3% |
| 5 | $181.81 | 5,517 | $1.0M | 15.4% |
| 6 | $181.81 | 5,517 |
| $1.0M |
| 15.4% |
| 7 | $182.60 | 717 | $131K | 2.0% |
| 8 | $182.60 | 717 | $131K | 2.0% |
| Total | $181.09 avg | 36,000 | $6.5M | 100% |
| Filing → |
| JAZZ | SELL | 2026-07-06 | $1.4M | — | Filing → |
| JAZZ | SELL | 2026-06-03 | $1.4M | — | Filing → |
| JAZZ | SELL | 2026-05-05 | $1.2M | — | Filing → |